legial dialogue will lead to greater collaboration, to more research that is highly attuned to community-based providers' actual needs and problems, and to greater use of sciencebased treatment and prevention practices in communitybased programs.
In each issue of Perspectives, distinguished scientists will review and interpret key research findings in areas of immediate relevance for practitioners, and highly accomplished and respected providers will discuss their experiences with implementing science-based programs and raise questions for research.
The articles in this inaugural Perspectives exemplify the equal and complementary contributions that practitioners and researchers can make toward advancing drug abuse treatment and prevention:
• James Sorensen, Carmen Masson, and David Perlman review the science of HIV and hepatitis prevention among drug abusers, focusing on practical steps programs canand should-take to contain these deadly diseases.
• Thomas Kosten and Tony George explain how drugs affect the brain to produce drug liking, tolerance, and addiction. Their plain-language account will help clinicians understand and convey to patients the biological basis for many of the phenomena encountered in treatment and recovery.
• T. Ron Jackson discusses the new challenge facing opioid treatment programs to achieve and document favorable patient outcomes, identifying research-based tools available to the programs, but also pointing out research opportunities related to the new standards.
• Ann Uhler and Olga Parker address treatment programs and researchers with the troubling possibility that the use of standardized trauma assessment instruments in initial interviews may drive some patients away from treatment. 
